malondialdehyde has been researched along with alpha-synuclein in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Ayala, V; Dalfó, E; Ferrer, I; Martínez, A; Pamplona, R; Portero-Otín, M | 1 |
| Moreira, PI; Perry, G; Sayre, LM; Smith, MA | 1 |
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Ferrer, I; Gomez, A | 1 |
| Chen, NH; Han, N; Ma, KL; Song, LK; Yuan, YH | 1 |
| Deng, Z; Pu, X; Sun, Y; Zhao, X; Zhou, J | 1 |
| Aerts, H; Dekker, N; Dermentzaki, G; Dimitriou, E; Michelakakis, H; Monopolis, I; Moraitou, M; Stefanis, L | 1 |
| Deng, Y; Duan, J; Lin, F; Su, Y; Ying, Z | 1 |
| Dai, L; Kuang, S; Li, J; Rao, Z; Tang, X; Yang, L; Zhong, H; Zhong, Z | 1 |
| Adem, A; Azimullah, S; Beiram, R; Jalal, FY; Jayaraj, RL; Meeran, MFN; Ojha, SK | 1 |
| Abdel Fattah, S; El-Enein, AA; Kamel, A; Labib, H; Waly, H | 1 |
| Abdel-Aziz, AM; AbdelWahab, SA; Haleem, M; Ibrahim, MA | 1 |
| Mohajeri, D; Nourazar, MA; Sokouti, H | 1 |
1 review(s) available for malondialdehyde and alpha-synuclein
| Article | Year |
|---|---|
Metal ions and oxidative protein modification in neurological disease.
Topics: Aldehydes; alpha-Synuclein; Alzheimer Disease; Animals; Cross-Linking Reagents; Encephalomyelitis, Autoimmune, Experimental; Free Radicals; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Malondialdehyde; Metals; Mice; Multiple Sclerosis; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Proteins; Rats; Reactive Oxygen Species | 2005 |
12 other study(ies) available for malondialdehyde and alpha-synuclein
| Article | Year |
|---|---|
Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
Topics: Aged; Aged, 80 and over; Aldehydes; alpha-Synuclein; Blotting, Western; Docosahexaenoic Acids; Electrophoresis, Gel, Two-Dimensional; Fatty Acids; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lewy Body Disease; Male; Malondialdehyde; Mass Spectrometry; Neocortex; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Synucleins | 2005 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cerebral Cortex; Cognition Disorders; Electrophoresis, Gel, Two-Dimensional; Female; Glial Fibrillary Acidic Protein; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Malondialdehyde; Mass Spectrometry; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serine; Statistics, Nonparametric | 2010 |
Over-expression of α-synuclein 98 triggers intracellular oxidative stress and enhances susceptibility to rotenone.
Topics: alpha-Synuclein; Animals; Blotting, Western; Cell Line; Cell Survival; Humans; Malondialdehyde; Neurons; Oxidative Stress; Protein Isoforms; Rats; Reactive Oxygen Species; Rotenone; Uncoupling Agents | 2011 |
3-O-demethylswertipunicoside inhibits MPP⁺-induced oxidative stress and apoptosis in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; Blotting, Western; Dopamine Agents; Glucosides; Malondialdehyde; Mitochondria; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthones | 2013 |
α-Synuclein dimerization in erythrocytes of Gaucher disease patients: correlation with lipid abnormalities and oxidative stress.
Topics: Adolescent; Adult; Aged; alpha-Synuclein; Case-Control Studies; Ceramides; Child, Preschool; Dimerization; Erythrocytes; Gaucher Disease; Humans; Lipids; Malondialdehyde; Middle Aged; Oxidative Stress; Plasmalogens; Young Adult | 2016 |
α-Synuclein binds to cytoplasmic vesicles in U251 glioblastoma cells.
Topics: alpha-Synuclein; Brain Neoplasms; Cell Line, Tumor; Cytoplasmic Vesicles; Glioblastoma; Humans; Hydrogen Peroxide; Malondialdehyde; Oxidative Stress; Protein Binding | 2017 |
Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease.
Topics: Alanine; alpha-Synuclein; Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Ginkgo biloba; Glutathione; Glutathione Peroxidase; Locomotion; Malondialdehyde; Mice; Mice, Transgenic; Muscle Strength; Mutation; Parkinson Disease; Plant Extracts; Superoxide Dismutase; Swimming; Threonine | 2018 |
Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Antioxidants; Brain; Catalase; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dopaminergic Neurons; Glutathione; Inflammation; Inflammation Mediators; Lipid Peroxidation; Lycopodium; Male; Malondialdehyde; Matrix Metalloproteinases; Microglia; Nerve Degeneration; Neuroprotection; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; Parkinson Disease; Plant Extracts; Rats, Wistar; Rotenone; Superoxide Dismutase | 2019 |
Mesenchymal stem cells versus curcumin in enhancing the alterations in the cerebellar cortex of streptozocin-induced diabetic albino rats. The role of GFAP, PLC and α-synuclein.
Topics: alpha-Synuclein; Animals; Blood Glucose; Cerebellar Cortex; Curcumin; Diabetes Mellitus, Experimental; Glial Fibrillary Acidic Protein; Glutathione; Male; Malondialdehyde; Mesenchymal Stem Cells; Oxidative Stress; Purkinje Cells; Rats; Signal Transduction; Superoxide Dismutase; Type C Phospholipases | 2020 |
Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats.
Topics: alpha-Synuclein; Aluminum Chloride; Alzheimer Disease; Animals; Brain; Cyclic GMP; Glutathione; Male; Malondialdehyde; Memory; Nestin; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats; Sildenafil Citrate; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2021 |
6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy.
Topics: alpha-Synuclein; Animals; Antioxidants; Apomorphine; Curcumin; Disease Models, Animal; Glutathione Peroxidase; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Oxidopamine; Parkinson Disease; Rats; Substantia Nigra | 2022 |